title: Laboratory monitoring of low-molecular-weight heparin therapy--part II. Monitoring LMWH therapy? For the moment a non-question.
authors.affiliation: Synapse BV, Cardiovascular Research Institute, Maastricht, the Netherlands. hc.hemker@thrombin.com
authors.forename: H C
authors.initials: HC
authors.lastname: Hemker
authors.forename: R
authors.initials: R
authors.lastname: Al Dieri
authors.forename: S
authors.initials: S
authors.lastname: Béguin
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects; D016903:Drug Monitoring / Q000379:methods*; D006495:Heparin, Low-Molecular-Weight / Q000493:pharmacokinetics*; D006801:Humans; D010314:Partial Thromboplastin Time; D013917:Thrombin / Q000037:antagonists & inhibitors
chemical_list: D006495:Heparin, Low-Molecular-Weight; D013917:Thrombin